News

Centre proposes limited use of drugs before phase III trials to speed innovation

BMJ 2013; 346 doi: https://doi.org/10.1136/bmj.f1824 (Published 20 March 2013) Cite this as: BMJ 2013;346:f1824
  1. Nigel Hawkes
  1. 1London

Oxford University and University College London have launched a new centre designed to turn scientific creativity into cures more swiftly and effectively.

The Centre for Advancement of Sustainable Medical Innovation will be directed by Richard Barker, former director general of the Association of the British Pharmaceutical Industry. It brings together many experts to try to solve what it calls one of the most important problems of the 21st century: transforming bioscience into benefits for patients.

Barker said, “We will tackle the three main ‘gaps in translation’: breakthroughs in the lab not producing therapies for trial; too …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe